EligibleTrials

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

Recruiting · NCT07226258 · Interventional (participants receive a specific treatment) · Lead sponsor: Saol Therapeutics Inc

View the official record on ClinicalTrials.gov →
Osteoarthritis

Interventions studied

Normal SalineSL1002

What this trial is about

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.

Who can take part

Age range
40 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

22 locations listed across 13 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.